病毒相关肽
Peptide Name | CAT# | Peptide Sequence |
HBV Seq1 aa: 141-151 | 1972-2-1 | Ser-Thr-Leu-Pro-Glu-Thr-Thr-Val-Val-Arg-Arg |
HBV Seq1 aa: 18-27 | 1972-2-2 | Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val |
HBV Seq1 aa: 63-71 | 1972-2-3 | Gly-Glu-Leu-Met-Thr-Leu-Ala-Thr-Trp |
HBV Seq1 aa: 93-100 | 1972-2-4 | Met-Gly-Leu-Lys-Ile-Arg-Gln-Leu |
HBV Seq2 aa: 179-186 | 1972-2-5 | Phe-Val-Gln-Trp-Phe-Val-Gly-Leu |
HBV Seq2 aa: 208-216 | 1972-2-6 | Ile-Val-Ser-Pro-Phe-Ile-Pro-Leu-Leu |
HBV Seq2 aa: 208-216 | 1972-2-7 | Ile-Leu-Ser-Pro-Phe-Leu-Pro-Leu-Leu |
HBV Seq2 aa: 28-39 | 1972-2-8 | Ile-Pro-Gln-Ser-Leu-Asp-Ser-Trp-Trp-Thr-Ser-Leu |
Hepatitis B Virus Pre-S Region (120-145) | 1972-2-9 | Met-Gln-Trp-Asn-Ser-Thr-Thr-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Phe-Pro-Ala-Gly-Gly |
Hepatitis B Virus Receptor Binding Fragment | 1972-2-10 | Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro |
[Ala127] Hepatitis B Virus Pre-S Region (120-131) | 1972-2-11 | Met-Gln-Trp-Asn-Ser-Thr-Ala-Phe-His-Gln-Thr |
Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys | 1972-2-12 | Ac-Asp-DGla-Leu-Ile-Cha-Cys |
Ac-Glu-Glu-Val-Val-Ala-Cys-AMC | 1972-2-13 | Ac-Glu-Glu-Val-Val-Ala-Cys-AMC |
Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | 1972-2-14 | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA |
Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala | 1972-2-15 | Glu-Ala-Gly-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Tyr-Thr-Trp-Thr-Gly-Ala |
HCV Core Protein (107-114) | 1972-2-16 | Trp-Gly-Pro-Asn-Asp-Pro-Arg-Arg |
HCV Core Protein (19-25) | 1972-2-17 | Pro-Gln-Asp-Val-Lys-Phe-Pro |
HCV Core Protein (59-68) | 1972-2-18 | Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala |
HCV NS4A Protein (18-40) (JT strain) | 1972-2-19 | Leu-Thr-Thr-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-Pro-Ala-Val-Val-Pro-Asp |
HCV NS4A Protein (21-34) (JT strain) | 1972-2-20 | Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg |
HCV Peptide Aa: 257-266 | 1972-2-21 | Thr-Ile-Arg-Arg-His-Val-Asp-Leu-Leu-Val |
HCV Peptide Aa: 35-44 | 1972-2-22 | Tyr-Leu-Leu-Pro-Arg-Arg-Gly-Pro-Arg-Leu |
HCV Peptide Aa:131-140 | 1972-2-23 | Ala-Asp-Leu-Met-Gly-Tyr-Ile-Pro-Leu-Val |
HCV-1 e2 Protein (484-499) | 1972-2-24 | Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-Ile-Val-Pro-Ala |
HCV-1 e2 Protein (554-569) | 1972-2-25 | Trp-Met-Asn-Ser-Thr-Gly-Phe-Thr-Lys-Val-Cys-Gly-Ala-Pro-Pro-Cys |
Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | 1972-2-26 | Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys | 1972-2-27 | Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | 1972-2-28 | Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-OH | 1972-2-29 | Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys |
Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-p-nitro-Phe-Leu | 1972-3-1 | Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-Ser-Gly-Ser-(NO2)Phe-Leu |
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys | 1972-3-2 | Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys |
Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-p-nitro-Phe-Lys-Lys-NH2 | 1972-3-3 | Mca-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-(NO2)Phe-Lys-Lys-NH2 |
Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | 1972-3-4 | Ser-Abu-Ser-Tyr-Lys-Lys-NH2 |
Ser-Gly-Ser-p-nitro-Phe-Leu | 1972-3-5 | Ser-Gly-Ser-(NO2)Phe-Leu |
2F5 epitope | 1972-3-6 | Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn |
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 1972-3-7 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 |
Alloferon 1 | 1972-3-8 | His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly |
Alloferon 2 | 1972-3-9 | Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly |
DABCYL-y-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 1972-3-10 | 4-(4-Dimethylaminophenylazo)benzoyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl)amino]-naphthalene-1-sulfonic acid |
ELDKWA | 1972-3-11 | Glu-Leu-Asp-Lys-Trp-Ala |
Herpes Virus Inhibitor 1 | 1972-3-12 | Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu |
Herpes Virus Inhibitor 2 | 1972-3-13 | Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu |
HIV (gp120) (318-327) | 1972-3-14 | Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile |
HIV Envelope Protein (254-274) | 1972-3-15 | Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu |
HIV Gag (129-135 ) | 1972-3-16 | Ser-Glu-Asn-Tyr-Pro-Ile-Val |
HIV Substrate | 1972-3-17 | Lys-Ala-Arg-Val-Nle-Phe(NO2)-Glu-Ala-Nle-NH2 |
Peptide T | 1972-3-18 | Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr |
R15K, HIV-1 Inhibitory Peptide | 1972-3-19 | Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys |
[3,5 Diiodo-Tyr7] Peptide T | 1972-3-20 | Ala-Ser-Thr-Thr-Thr-Asn-(3,5 diiodo)Tyr-Thr |
[Cys(Bzl)84] CD (81-92) | 1972-3-21 | Thr-Tyr-Ile-Cys(benzyl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu |
[DAla1] Peptide T, amide | 1972-3-22 | DAla-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 |
gp120, HIV-1 MN | 1972-3-23 | Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile |
gp38 | 1972-3-24 | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys |
HA Peptide | 1972-3-25 | Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala |
HIV-1, HIV-2 Protease Substrate | 1972-3-26 | Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp |
Lactalbumin B (50-53) Alpha [Lactorphin Alpha], bovine | 1972-3-27 | Tyr-Gly-Leu-Phe |
VSV-G Peptide | 1972-3-28 | Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys |
,